image description

Tag: LLDAS

Treat-to-Target is Feasible and Beneficial in Lupus

September 19, 2019 Treating patients with lupus until they reach specific health goals can reduce disease flares and prevent organ damage, according to a research team co-led by Professor Eric F. Morand, at Monash University in Australia and past recipient of the Distinguished Innovator Award from the Lupus Research Alliance (LRA). This study is important […] Read More

Recognizing Remission in Lupus

October 30, 2018 Researchers are trying to ascertain the important issue in SLE of how much improvement in disease activity patients must show to decrease the long-term rate of organ damage.  Four studies presented at ACR by Drs. Eric Morand and Michelle Petri addressed that important question. Favorable Results for “Easier” Remission Target Three studies […] Read More